Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,834.50
  • Today's Change-26.00 / -1.40%
  • Shares traded1.55m
  • 1 Year change43.21%
  • Beta0.3272
Data delayed at least 20 minutes, as of Oct 15 2019 16:36 BST.
More ▼

Key statistics

On Tuesday, Smith & Nephew PLC (SN.:LSE) closed at 1,834.50, -8.20% below its 52-week high of 1,998.40, set on Sep 03, 2019.
52-week range
Today
1,242.50Oct 26 20181,998.40Sep 03 2019
Markit short selling activity
Low
Med
High
Open1,850.00
High1,871.00
Low1,833.00
Bid1,810.00
Offer1,880.50
Previous close1,860.50
Average volume2.04m
Shares outstanding874.64m
Free float871.86m
P/E (TTM)29.52
Market cap16.33bn GBP
EPS (TTM)0.6324
GBP
Annual div (ADY)28.49
GBX
Annual div yield (ADY)1.53%
Div ex-dateOct 03 2019
Div pay-dateOct 30 2019
Data delayed at least 20 minutes, as of Oct 15 2019 16:36 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Buy at 1,894.00 on 31 Jul 2019Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.